Orthofix Medical News

Express News | Orthofix Names Max Reinhardt President of Global Spine Business

BreakingsMay 23 19:00

Orthofix Wins "Best Patient Experience Solution" Award in 2024 MedTech Breakthrough Awards Program

Orthofix Medical Inc. (NASDAQ:OFIX), a leading global spine and orthopedics company, today announced that it has been selected as winner of the "Best Patient Experience Solution" award in the 8th annual MedTech

BusinesswireMay 16 19:00

Orthofix Medical's (OFIX) Telescopic Nail Gets FDA Clearance

Yahoo FinanceMay 13 23:18

Orthofix Gets FDA Clearance for Rodeo Telescopic Nail

Seeking AlphaMay 10 01:50

Orthofix Announces FDA 510(k) Clearance for the Rodeo Telescopic Nail

Orthofix Medical Inc. (NASDAQ:OFIX), a leading global spine and orthopedics company, today announced that it has received U.S. Food and Drug Administration (FDA) 510(k) clearance to market its Rodeo Telescopic

BusinesswireMay 9 19:00

Orthofix Medical Inc. (NASDAQ:OFIX) Q1 2024 Earnings Call Transcript

Yahoo FinanceMay 9 01:03

Roth MKM Ups Orthofix to Buy, Cites Improving Fundamentals

Seeking AlphaMay 9 00:50

Datadog To Rally Around 25%? Here Are 10 Top Analyst Forecasts For Wednesday

Top Wall Street analysts changed their outlook on these top names. For a complete view of all analyst rating changes, including upgrades and downgrades, please see our analyst ratings page.Piper Sandl

BenzingaMay 8 20:43

Roth MKM Upgrades Orthofix Medical to Buy From Neutral With $20 Price Target

Orthofix Medical (OFIX) has an average outperform rating and a price target range of $14 to $26.40, according to analysts polled by Capital IQ.

MT NewswiresMay 8 19:43

Orthofix Medical Raised to Buy From Neutral by Roth MKM

Orthofix Medical Raised to Buy From Neutral by Roth MKM

Dow JonesMay 8 18:00

Orthofix Medical Price Target Raised to $20.00/Share From $15.00 by Roth MKM

Orthofix Medical Price Target Raised to $20.00/Share From $15.00 by Roth MKM

Dow JonesMay 8 18:00

Roth MKM: Upgraded Orthofix Medical (OFIX.US) rating from neutral to buy rating, and adjusted target price from $15.00 to $20.00

Roth MKM: Upgraded Orthofix Medical (OFIX.US) rating from neutral to buy rating, and adjusted target price from $15.00 to $20.00

Zhitong FinanceMay 8 17:51

Roth MKM Upgrades Orthofix Medical to Buy, Raises Price Target to $20

Roth MKM analyst Jason Wittes upgrades Orthofix Medical (NASDAQ:OFIX) from Neutral to Buy and raises the price target from $15 to $20.

BenzingaMay 8 17:49

Orthofix Medical Inc (OFIX) Q1 2024 Earnings Call Transcript Highlights: Robust Growth and ...

Yahoo FinanceMay 8 15:16

Q1 2024 Orthofix Medical Inc Earnings Call

Yahoo FinanceMay 8 10:38

Orthofix Medical Inc. (OFIX) Q1 2024 Earnings Call Transcript

Orthofix Medical Inc. (OFIX) Q1 2024 Earnings Call Transcript

Earnings Call TranscriptsMay 8 01:36

Orthofix Medical Inc. Q1 Loss Decreases, but Misses Estimates

RTTNewsMay 7 20:27

Orthofix Cuts FY24 Revenue Outlook From $785M - $795M To $790M - $795M Vs. $790.82M Est.

Orthofix Cuts FY24 Revenue Outlook From $785M - $795M To $790M - $795M Vs. $790.82M Est.

BenzingaMay 7 20:11

Earnings Flash (OFIX) ORTHOFIX MEDICAL Reports Q1 Revenue $188.6M

08:11 AM EDT, 05/07/2024 (MT Newswires) -- Earnings Flash (OFIX) ORTHOFIX MEDICAL Reports Q1 Revenue $188.6M

MT NewswiresMay 7 20:11

Orthofix Medical | 10-Q: Quarterly report

SEC announcementMay 7 20:09 · Announcements